metabolic syndrome. Other disorders of lipoprotein metabolism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women who have three indicators of Indices metabolic syndrome; Having written informed consent; Constant treatment for 3 months; Age between 30 - 59 years. Exclusion criteria: Pregnancy or Breastfeeding; Any skin or Digestive allergy to purslane; Have any underlying disease (autoimmune diseases, gastrointestinal, live, thyroid, unstable heart disease ).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: Before the start of the study and 12 weeks after intervention. Method of measurement: blood biochemical test.;Blood pressure. Timepoint: before ,during and 12 weeks after starting intervention. Method of measurement: Mercury Barometer.;HDL. Timepoint: Before the start of the study and 12 weeks after intervention. Method of measurement: blood biochemical test.;TG. Timepoint: Before the start of the study and 12 weeks after intervention. Method of measurement: blood biochemical test.;Waist. Timepoint: Before the start of the study and 12 weeks after intervention. Method of measurement: cm using meter. | — |
Secondary
| Measure | Time frame |
|---|---|
| LDL. Timepoint: before and 12 weeks ofter starting intervention. Method of measurement: blood biochemical test.;TC. Timepoint: before and 12 weeks ofter starting intervention. Method of measurement: blood biochemical test.;Weight. Timepoint: before and 12 weeks ofter starting intervention. Method of measurement: digital scale.;Height. Timepoint: before and 12 weeks ofter starting intervention. Method of measurement: meter.;BMI. Timepoint: before and 12 weeks ofter starting intervention. Method of measurement: meter and digital scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
International Campus, Shahid Sadoughi University of Medical Sciences